HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon Announces Cost-Cutting Plan; CoverGirl’s Flagship Store; More Cosmetics News In Brief

This article was originally published in The Rose Sheet

Executive Summary

Revlon responds to continued net losses with a cost-cutting plan, which will include headcount reductions; Coty is optimistic that CoverGirl momentum, including the launch of a flagship store in Times Square, will help buoy its struggling Consumer Beauty business. Meanwhile, L’Oreal/La Roche-Posay introduces a wearable UV sensor, and IFF-LMR promotes its vegan-certified natural extracts.

You may also be interested in...



Leading Beauty Brands Harness Tech Innovations For Personalized Solutions; CES News In Brief

P&G, J&J/Neutrogena and L’Oreal/La Roche-Posay are among firms exhibiting technologies at the Consumer Electronics Showcase in Las Vegas that provide personalized skin benefits.

Coty Announces New CEO, Board Changes Following Troubled Q1

Coty reported Nov. 7 a Q1 revenue decline of 9.2% due to a constellation of supply-chain issues and continued Consumer Beauty weakness. Less than a week later – and two years after its completion of a $12bn merger with P&G’s beauty business – the firm announces Pierre Laubies as CEO, evidently drawn to his experience integrating combined assets at a Dutch coffee company.

L'Oreal's UV Sense Doubles As Sun Exposure Monitor, Thumbnail Art

Measuring less than 2mm thick and 9mm in diameter, UV Sense is intended to be worn on a user’s thumbnail for up to two weeks at a time, relaying UV exposure measurements to a companion app that organizes the data and offers protective care recommendations. The device will launch from La Roche-Posay on a limited basis in the US this summer.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS122503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel